Economic evaluation of new oral anticoagulants in prevention of venous thrombosis following joint replacement surgery: a systematic review

A Rezapour, A Souresrafil, J Arabloo - Clinical Therapeutics, 2021 - Elsevier
cost-effective than apixaban and dabigatran from a perspective of the health care system in
the prevention of … end points, such as the number of VTE cases avoided or life-years saved. …

[HTML][HTML] Comparison of clinical effects and costs among dabigatran etexilate, rivaroxaban and warfarin in elderly patients with atrial fibrillation

J Di, Y Wei, G Zhang, Y Yue, S Sun - American Journal of …, 2023 - ncbi.nlm.nih.gov
… ventricular posterior wall in end diastole and increased minimum … However, many
pharmacoeconomic studies showed that in … in patients with cerebral venous thrombosis: a …

Economic evaluation of rivaroxaban versus enoxaparin for prevention of venous thromboembolism after total knee replacement and total hip replacement: a …

A Rashki Kemmak, A Abutorabi, V Alipour - Clinical Drug Investigation, 2020 - Springer
cost-effectiveness analyses of rivaroxaban versus enoxaparin for the prevention of VTE (the
result of a venous blood clot … using rivaroxaban, which was used to prevent VTE, and it was …

[HTML][HTML] Dabigatran in cardiovascular disease management: A comprehensive review

A Javed, M Ajmal, A Wolfson - World journal of cardiology, 2021 - ncbi.nlm.nih.gov
thrombosis and pulmonary embolism, stroke prevention in non-… were continued on this
regimen until the end of the study. … One Canadian study demonstrated dabigatran to be highly cost

[HTML][HTML] Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in Low and Middle-Income Countries: A …

A Souresrafil, A Abutorabi… - Medical Journal of the …, 2022 - ncbi.nlm.nih.gov
… These anticoagulants are used to prevent blood clots formation and reduce the risk of stroke
dabigatran 110, 150 mg (29). But in Rattanachotphanit's study, dabigatran was more cost-…

[HTML][HTML] Cost-Effectiveness Rivaroxaban versus Enoxaparin for Prevention of Venous Thromboembolism after Knee Replacement Surgery in Iran

A Abutorabi, MH Ahmadi, SB Faradonbeh… - Medical Journal of the …, 2023 - ncbi.nlm.nih.gov
… as blood clots, is a disorder that includes deep vein thrombosis … that new treatments can
effectively prevent this disease, it … and more effective than dabigatran. After performing a …

Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review …

SK Veettil, J Harris, MS Syeed, A Thakkinstian… - Thrombosis …, 2022 - Elsevier
… are important agents to prevent VTE and pulmonary embolism … the cost-effectiveness of
using DOACs for the prevention of … the cost-effectiveness of DOACs suggested that dabigatran

[HTML][HTML] Thromboprophylaxis of patients submitted to total hip and knee arthroplasty: a cost-effectiveness assessment from the perspective of the Brazilian National …

AFS de Brito, NC Brito, SKT Tanaka, VL Ferreira… - Value in Health …, 2022 - Elsevier
… This pharmacoeconomic analysis aimed to identify the most cost… In Brazil, the investment
to reduce and prevent VTE can … : antithrombotic therapy and prevention of thrombosis. 9th ed: …

Budget and health impact of switching eligible patients with atrial fibrillation to lower-dose dabigatran

T Fens, L de Jong, B Kappelhoff, C Boersma… - Journal of Market …, 2023 - mdpi.com
… or rivaroxaban to dabigatran resulted in cost savings estimated at … Dabigatran etexilate [8]
acts as direct thrombin inhibitor, while … compared with rivaroxaban for prevention of stroke and …

[HTML][HTML] Anticoagulant therapy for stroke prevention in people with atrial fibrillation

NGC UK - 2021 - ncbi.nlm.nih.gov
… that apixaban was cost effective compared to warfarin, dabigatran, … Cost-effectiveness of
dabigatran etexilate for the prevention of … Thrombosis and Haemostasis. 2011; 105(5):908–919 […